Integral Health Asset Management Boosts Stake in Rezolute, Inc.

The investment firm increased its position in the biopharmaceutical company by 11.1% in the third quarter.

Mar. 14, 2026 at 8:48am

Got story updates? Submit your updates here. ›

Integral Health Asset Management LLC increased its stake in Rezolute, Inc. (NASDAQ:RZLT) by 11.1% during the third quarter, according to a recent report. The firm now owns 2,000,000 shares of the company's stock, worth approximately $18.8 million, making it one of Rezolute's largest institutional investors.

Why it matters

Rezolute is a clinical-stage biopharmaceutical company developing therapies for metabolic diseases associated with chronic glucose imbalance. Integral Health Asset Management's increased investment signals confidence in the company's pipeline and future growth potential.

The details

Integral Health Asset Management acquired an additional 200,000 shares of Rezolute during the third quarter, bringing its total position to 2,000,000 shares. This represents approximately 1.3% of the firm's total investment portfolio. Other notable institutional investors in Rezolute include the New York State Common Retirement Fund and JPMorgan Chase & Co.

  • Integral Health Asset Management increased its stake in Rezolute during the third quarter of 2026.

The players

Integral Health Asset Management LLC

An investment management firm that has increased its stake in Rezolute, Inc.

Rezolute, Inc.

A clinical-stage biopharmaceutical company developing therapies for metabolic diseases.

Got photos? Submit your photos here. ›

The takeaway

Integral Health Asset Management's increased investment in Rezolute suggests the firm sees significant growth potential in the biopharmaceutical company's pipeline of metabolic disease treatments. This could signal positive developments ahead for Rezolute as it continues to advance its clinical programs.